Goldman Sachs
VANI icon

Goldman Sachs’s Vivani Medical VANI Stock Holding History

Goldman Sachs’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-46
Closed -$2K – 5692
2018
Q3 		$2K Hold
46
– – ﹤0.01% 5535
2018
Q2 		$2K Hold
46
– – ﹤0.01% 5608
2018
Q1 		$2K Buy
+46
New +$2.05K ﹤0.01% 5837
2016
Q3 		– Sell
-13
Closed -$1K – 7197
2016
Q2 		$1K Sell
13
-245
-95% -$25.5K ﹤0.01% 6987
2016
Q1 		$30K Sell
258
-267
-51% -$30.7K ﹤0.01% 6618
2015
Q4 		$74K Sell
525
-25
-5% -$3.66K ﹤0.01% 6332
2015
Q3 		$78K Buy
550
+192
+54% +$53.3K ﹤0.01% 6615
2015
Q2 		$117K Buy
+358
New +$115K ﹤0.01% 6528

Other funds holding VANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs's VANI Position: Q3 2025 in Review

Goldman Sachs sold out of Vivani Medical (VANI) in Q3 2025, closing a stake of 14,423 shares — an estimated $18.6K sold.

Goldman Sachs first reported a position in VANI in Q4 2014 and held it in 25 quarters. The position peaked at $533K in Q3 2015. 29 funds tracked by Wall St. Rank hold VANI as of Q3 2025.

  • Goldman Sachs reported no remaining Vivani Medical position as of Q3 2025 after selling out during the quarter.
  • Goldman Sachs sold 14,423 Vivani Medical shares in Q3 2025, an estimated $18.6K.
  • Goldman Sachs first reported a position in Vivani Medical in Q4 2014 and held it in 25 quarters.
  • Goldman Sachs's Vivani Medical position peaked at $533K in Q3 2015.
  • 29 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.